CRISPR Therapeutics’ Casgevy Therapy Offers New Sickle Cell Treatment at Children’s Wisconsin
This medical breakthrough is a significant step forward in treating Sickle Cell Disease SCD in Wisconsin, with the FDA’s recent approval of the gene-editing Casgevy therapy developed by CRISPR Therapeutics. The therapy works by modifying a patient’s own …